Stratification of ALS patients’ survival: a population-based study

Journal of Neurology

Volumn 263, Issue 1, 2016, Pages 100-111

  Marin, Benoît ^a,b,c   Couratier, Philippe ^a,b   Arcuti, Simona ^c   Copetti, Massimiliano ^d   Fontana, Andrea ^d   Nicol, Marie ^a,b   Raymondeau, Marie ^a,b   Logroscino, Giancarlo ^c   Preux, Pierre Marie ^a,b  

^a UNIVERSITÉ DE LIMOGES   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY OF BARI   (Italy)

^d CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Epidemiology; Mortality; Prognosis; Survival

Indexed keywords

AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIAN SURVIVAL TIME; MORTALITY; PHYSICIAN; PRIORITY JOURNAL; PROGNOSIS; REGISTER; RISK ASSESSMENT; STRATIFIED SAMPLE; CLASSIFICATION; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS; TIME FACTOR;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; REGISTRIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 84955715255     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-015-7940-z     Document Type: Article

References (60)

1. Logroscino G, Tortelli R, Rizzo G et al (2015) Amyotrophic lateral sclerosis: an aging-related disease. Curr Geri Rep 4:142–153
2. Beghi E, Logroscino G, Chio A et al (2006) The epidemiology of ALS and the role of population-based registries. Biochim Biophys Acta 1762:1150–1157
3. Zoccolella S, Beghi E, Palagano G et al (2008) Predictors of long survival in amyotrophic lateral sclerosis: a population-based study. J Neurol Sci 268:28–32
4. Mitsumoto H, Brooks BR, Silani V (2014) Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved? Lancet Neurol 13:1127–1138
5. Institut National de la Statistique et des Etudes Economiques (2013) Estimation de la population au 1er janvier par région, département (1975−2012), sexe et âge. [cited 2015 Jan 09]; Available at: http://www.insee.fr/fr/themes/detail.asp?ref_id=estim-pop®_id=99
6. Marin B, Hamidou B, Couratier P et al (2014) Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe: the French register of ALS in Limousin (FRALim register). Eur J Neurol 21:1292–1300
7. Brooks BR, Miller RG, Swash M et al (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293–299
8. The Amyotrophic Lateral Sclerosis Functional Rating Scale (1996) Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I–II Study Group. Arch Neurol 53:141–147
9. Cedarbaum JM, Stambler N, Malta E et al (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169:13–21
10. Allison P (1995) Survival analysis using the SAS system: a practical guide. SASInstitute, Cary NC
11. Ambler G, Royston P (2001) Fractional polynomial model selection procedures: investigation of Type I error rate. J Stat Simul Comput 69:89–108
12. Institut National de la Statistique et des Etudes Economiques. Décès selon l’âge atteint dans l’année. Séries depuis 1962 pour la France métropolitaine, 1994 pour la France entière. [cited 2014 Jun 25]; Available at: http://www.insee.fr/fr/themes/detail.asp?reg_id=0&ref_id=ir-irsocsd20133.13
13. Ciampi A (1991) Generalized regression tree. Comput Stat Data Anal 12:57–78
14. Chio A, Logroscino G, Hardiman O et al (2009) Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler 10:310–323
15. Von Elm E, Altman DG, Egger M et al (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453–1457
16. Pupillo E, Messina P, Logroscino G et al (2014) Long-term survival in amyotrophic lateral sclerosis: a population-based study. Ann Neurol 75:287–297
17. Zoccolella S, Beghi E, Palagano G et al (2008) Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 79:33–37
18. Pugliatti M, Parish LD, Cossu P et al (2013) Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995–2009. J Neurol 260:572–579
19. Chio A, Calvo A, Moglia C et al (2011) Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 82:740–746
20. Bandettini Di Poggio M, Sormani MP, Truffelli R et al (2013) Clinical epidemiology of ALS in Liguria, Italy. Amyotroph Lateral Scler Frontotemporal Degener 14:52–57
21. Mandrioli J, Georgoulopoulou E, Fini N et al (2014) Prognosis factors for ALS in patients from Emilia Romagna, Italy: a population-based study. Amyotroph Lateral Scler Frontotemporal Degener 15:135
22. Murphy M, Quinn S, Young J et al (2008) Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study. Neurology 71:1889–1895
23. Okumura H (2003) Epidemiological and clinical patterns of western pacific amyotrophic lateral sclerosis (ALS) in Guam and sporadic ALS in Rochester, Minnesota, U.S.A. and Hokkaido, Japan: a comparative study. Hokkaido Igaku Zasshi 78:187–195
24. Rooney J, Byrne S, Heverin M et al. (2013) Survival analysis of Irish amyotrophic lateral sclerosis patients diagnosed from 1995–2010. PLoS ONE 8:e74733
25. Pradas J, Puig T, Rojas-Garcia R et al (2013) Amyotrophic lateral sclerosis in Catalonia: a population based study. Amyotroph Lateral Scler Frontotemporal Degener 14:278–283
26. Wolf J, Safer A, Wohrle JC et al (2015) Factors predicting survival in ALS patients—data from a population-based registry in Rhineland-Palatinate, Germany. Neuroepidemiology 44:149–155
27. Del Aguila MA, Longstreth WT Jr, Mcguire V et al (2003) Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 60:813–819
28. Huisman MH, De Jong SW, Van Doormaal PT et al. (2011) Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology. J Neurol Neurosurg Psychiatry 82:1165–1170
29. Gubbay SS, Kahana E, Zilber N et al (1985) Amyotrophic lateral sclerosis. A study of its presentation and prognosis. J Neurol 232:295–300
30. Sajjadi M, Etemadifar M, Nemati A et al (2010) Epidemiology of amyotrophic lateral sclerosis in Isfahan, Iran. Eur J Neurol 17:984–989
31. Christensen PB, Hojer-Pedersen E, Jensen NB (1990) Survival of patients with amyotrophic lateral sclerosis in 2 Danish counties. Neurology 40:600–604
32. Marin B, Logroscino G, Boumédiene F et al (2015) Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin. Eur J Epidemiol. doi:10.1007/s10654-015-0090-x
33. Forbes RB, Colville S, Cran GW et al (2004) Unexpected decline in survival from amyotrophic lateral sclerosis/motor neurone disease. J Neurol Neurosurg Psychiatry 75:1753–1755
34. Norris F, Shepherd R, Denys E et al (1993) Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci 118:48–55
35. Jordan H, Fagliano J, Rechtman L et al (2015) Effects of demographic factors on survival time after a diagnosis of amyotrophic lateral sclerosis. Neuroepidemiology 44:114–120
36. Mandrioli J, Biguzzi S, Guidi C et al (2015) Heterogeneity in ALSFRS-R decline and survival: a population-based study in Italy. Neurol Sci. doi:10.1007/s10072-015-2343-6
37. Turner MR, Bakker M, Sham P et al (2002) Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 3:15–21
38. Elamin M, Bede P, Montuschi A et al (2015) Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm. J Neurol 262:1447–1454
39. Atsuta N, Watanabe H, Ito M et al (2009) Age at onset influences on wide-ranged clinical features of sporadic amyotrophic lateral sclerosis. J Neurol Sci 276:163–169
40. Rabkin J, Ogino M, Goetz R et al (2014) Japanese and American ALS patient preferences regarding TIV (tracheostomy with invasive ventilation): a cross-national survey. Amyotroph Lateral Scler Frontotemporal Degener 15:185–191
41. Gil J, Vazquez MC, Ketzoian C et al (2009) Prognosis of ALS: comparing data from the Limousin referral centre, France, and a Uruguayan population. Amyotroph Lateral Scler 10:355–360
42. Logroscino G, Traynor BJ, Hardiman O et al (2008) Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry 79:6–11
43. Sorenson EJ, Mandrekar J, Crum B et al (2007) Effect of referral bias on assessing survival in ALS. Neurology 68:600–602
44. Lee JR, Annegers JF, Appel SH (1995) Prognosis of amyotrophic lateral sclerosis and the effect of referral selection. J Neurol Sci 132:207–215
45. Haverkamp LJ, Appel V, Appel SH (1995) Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 118(Pt 3):707–719
46. Armon C, Moses D (1998) Linear estimates of rates of disease progression as predictors of survival in patients with ALS entering clinical trials. J Neurol Sci 160(Suppl 1):S37–S41
47. Czaplinski A, Yen AA, Simpson EP et al (2006) Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing? Arch Neurol 63:1139–1143
48. Martinez HR, Molina-Lopez JF, Cantu-Martinez L et al (2011) Survival and clinical features in Hispanic amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler 12:199–205
49. Traynor BJ, Alexander M, Corr B et al (2003) Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000. J Neurol Neurosurg Psychiatry 74:1258–1261
50. Chio A, Canosa A, Gallo S et al (2011) ALS clinical trials: do enrolled patients accurately represent the ALS population? Neurology 77:1432–1437
51. United Nations. Demographic Year book. DYB Annual issues. [cited 2015 Jan 09]; Available at: http://unstats.un.org/unsd/demographic/products/dyb/dyb2.htm
52. Hook EB, Regal RR (1995) Capture–recapture methods in epidemiology: methods and limitations. Epidemiol Rev 17:243–264
53. Capozzo R, Quaranta VN, Pellegrini F et al (2015) Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis. J Neurol 262:593–603
54. Durante C, Costante G, Lucisano G et al (2015) The natural history of benign thyroid nodules. JAMA 313:926–935
55. Rizza S, Copetti M, Cardellini M et al (2015) A score including ADAM17 substrates correlates to recurring cardiovascular event in subjects with atherosclerosis. Atherosclerosis 239:459–464
56. Barulli MR, Fontana A, Panza F et al (2015) Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study. BMJ Open 5:e007069
57. Tavano F, Fontana A, Pellegrini F et al (2014) Modeling interactions between human equilibrative nucleoside transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients. J Transl Med 12:248
58. Mangia A, Santoro R, Copetti M et al (2013) Treatment optimization and prediction of HCV clearance in patients with acute HCV infection. J Hepatol 59:221–228
59. Muscarella LA, Barbano R, D’angelo V et al (2011) Regulation of KEAP1 expression by promoter methylation in malignant gliomas and association with patient’s outcome. Epigenetics 6:317–325
60. Steyerberg EW, Vickers AJ, Cook NR et al (2010) Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 21:128–138